Moreover, Cav-1 appears to be linked to many signalling entities within the GB tumour and as such this work begins to substantiate Cav-1 or its associated signalling partners as candidate target for GB new drug discovery which remains an unmet medical need. The gene discussed is CAV1; the disease is neoplasm.